Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2020-04-09 Regulatory Filings
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
109年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (旭富) providing information about fund loans and endorsement guarantees for the current and previous months, including cumulative amounts and limits. The content is very brief (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not present a full financial report, earnings release, or management discussion. It is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS).
2020-04-09 Chinese
109年3月營業收入
Regulatory Filings Classification · 95% confidence The document is a revenue summary report for a company named 旭富 for the period of March 2020 (民國109年03月). It contains numerical data on net operating revenue for the current month and year-to-date compared to the previous year, with percentage changes and notes on accounting standards (IFRS). The document is short (769 characters) and primarily provides summarized financial data without detailed financial statements or analysis. It does not appear to be a full annual or interim report, nor an earnings release or investor presentation. It is a regulatory disclosure of revenue figures, typical of a general regulatory announcement or compliance filing. Therefore, it fits best under Regulatory Filings (RNS).
2020-04-09 Chinese
係因本公司有價證券於集中交易市場達公布注意交易資訊 標準, 故公布相關財務業務資訊
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (4119 旭富) providing financial business information related to securities trading on the Taiwan Stock Exchange. It includes monthly and quarterly financial figures such as revenue, pre-tax profit, net profit, and earnings per share, with percentage changes compared to the previous year. The document is brief (1336 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial data rather than a full interim or annual report. There is no indication that this is a full quarterly or interim report (IR), nor an earnings release (ER) which typically highlights key results in a more summarized form. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-03-30 Chinese
108年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, holding percentages, and recognized investment gains or losses for a specific quarter (108th year, 4th quarter). The content is tabular and concise, focusing on investment details rather than a full financial report. The document length is only 648 characters, indicating it is a brief regulatory disclosure rather than a comprehensive report. There is no indication of it being an annual or interim report, audit report, or earnings release. It appears to be a regulatory filing providing specific investment information as required by securities regulations. Therefore, the best fitting category is Regulatory Filings (RNS).
2020-03-26 Chinese
108年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table showing key financial ratios and metrics for three fiscal years (106, 107, 108年度) for the company 旭富. The data includes financial structure, debt ratios, liquidity ratios, operational efficiency, profitability, and cash flow metrics. The document is relatively short (1019 characters) and presents summarized financial data over multiple years, but it does not contain detailed financial statements or comprehensive analysis typical of full annual or interim reports. It appears to be a brief financial summary or factsheet rather than a full report or announcement. There is no indication of it being a regulatory filing, announcement, or presentation. Given the concise nature and summary format, the best fitting category is Fund Information / Factsheet (FS).
2020-03-25 Chinese
108年度營益分析
Interim / Quarterly Report Classification · 85% confidence The document contains financial data segmented by fiscal periods such as first quarter, half-year, third quarter, and full year, with metrics like revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin. The data is presented in a tabular format and covers multiple years. The document length is only 1050 characters, which is quite short for a full financial report. There is no indication that this is an announcement or a notice about a report publication; rather, it contains actual financial data for interim periods. Given the presence of quarterly and half-year financial data, this fits the definition of an Interim / Quarterly Report (IR).
2020-03-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.